Kayne Anderson Rudnick Investment Management
NRC icon

Kayne Anderson Rudnick Investment Management’s NRC Health Common Stock NRC Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio NRC Stock Details NRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.8M Sell
2,636,355
-21,473
-0.8% -$365K 0.13% 127
2025
Q4 		$49.9M Sell
2,657,828
-92,730
-3% -$1.4M 0.13% 127
2025
Q3 		$35.2M Sell
2,750,558
-236,167
-8% -$3.54M 0.09% 162
2025
Q2 		$50.2M Sell
2,986,725
-37,784
-1% -$510K 0.12% 136
2025
Q1 		$38.7M Sell
3,024,509
-8,918
-0.3% -$143K 0.09% 150
2024
Q4 		$53.5M Sell
3,033,427
-26,149
-0.9% -$496K 0.12% 135
2024
Q3 		$69.9M Buy
3,059,576
+14,270
+0.5% +$322K 0.15% 120
2024
Q2 		$69.9M Buy
3,045,306
+18,891
+0.6% +$582K 0.17% 119
2024
Q1 		$120M Buy
3,026,415
+144,951
+5% +$5.73M 0.28% 98
2023
Q4 		$114M Sell
2,881,464
-313,165
-10% -$13.1M 0.29% 96
2023
Q3 		$142M Sell
3,194,629
-14,152
-0.4% -$618K 0.4% 72
2023
Q2 		$140M Sell
3,208,781
-2,599
-0.1% -$114K 0.39% 75
2023
Q1 		$140M Sell
3,211,380
-12,785
-0.4% -$565K 0.41% 71
2022
Q4 		$120M Sell
3,224,165
-8,830
-0.3% -$342K 0.38% 78
2022
Q3 		$129M Sell
3,232,995
-13,649
-0.4% -$505K 0.43% 74
2022
Q2 		$124M Sell
3,246,644
-53,895
-2% -$1.95M 0.39% 79
2022
Q1 		$131M Sell
3,300,539
-15,075
-0.5% -$590K 0.35% 89
2021
Q4 		$138M Sell
3,315,614
-21,459
-0.6% -$933K 0.32% 93
2021
Q3 		$141M Buy
3,337,073
+6,929
+0.2% +$349K 0.34% 93
2021
Q2 		$153M Sell
3,330,144
-68,295
-2% -$3.25M 0.38% 85
2021
Q1 		$159M Buy
3,398,439
+64,083
+2% +$3.11M 0.43% 80
2020
Q4 		$143M Buy
3,334,356
+109,255
+3% +$5.61M 0.41% 79
2020
Q3 		$159M Buy
3,225,101
+76,663
+2% +$4.24M 0.57% 63
2020
Q2 		$183M Buy
3,148,438
+128,441
+4% +$6.79M 0.76% 40
2020
Q1 		$137M Buy
3,019,997
+33,020
+1% +$1.98M 0.78% 35
2019
Q4 		$197M Buy
2,986,977
+16,693
+0.6% +$1.02M 0.95% 31
2019
Q3 		$172M Sell
2,970,284
-161,919
-5% -$10M 0.89% 34
2019
Q2 		$180M Sell
3,132,203
-11,176
-0.4% -$517K 0.95% 30
2019
Q1 		$121M Sell
3,143,379
-6,409
-0.2% -$251K 0.69% 39
2018
Q4 		$120M Buy
3,149,788
+102,706
+3% +$3.95M 0.83% 33
2018
Q3 		$118M Buy
3,047,082
+464,298
+18% +$17.6M 0.69% 39
2018
Q2 		$96.6M Buy
2,582,784
+279,760
+12% +$9.75M 0.62% 46
2018
Q1 		$67.4M Buy
2,303,024
+120,466
+6% +$4.04M 0.5% 53
2017
Q4 		$81.4M Buy
2,182,558
+112,364
+5% +$3.99M 0.66% 42
2017
Q3 		$78M Buy
2,070,194
+71,648
+4% +$2.25M 0.7% 44
2017
Q2 		$53.8M Buy
1,998,546
+7,276
+0.4% +$178K 0.54% 58
2017
Q1 		$39.2M Buy
1,991,270
+641,048
+47% +$11.9M 0.43% 73
2016
Q4 		$25.7M Buy
1,350,222
+106,741
+9% +$1.76M 0.31% 97
2016
Q3 		$20.3M Buy
1,243,481
+76,792
+7% +$1.21M 0.25% 115
2016
Q2 		$16M Buy
1,166,689
+207,647
+22% +$2.93M 0.24% 120
2016
Q1 		$14.9M Buy
959,042
+170,977
+22% +$2.51M 0.24% 117
2015
Q4 		$12.6M Buy
788,065
+72,829
+10% +$1.11M 0.21% 129
2015
Q3 		$8.54M Buy
715,236
+8,997
+1% +$119K 0.14% 143
2015
Q2 		$10M Buy
706,239
+126,814
+22% +$1.8M 0.16% 143
2015
Q1 		$8.34M Buy
579,425
+4,351
+0.8% +$61.5K 0.13% 144
2014
Q4 		$8.04M Buy
575,074
+52,350
+10% +$769K 0.13% 147
2014
Q3 		$6.8M Buy
522,724
+70,321
+16% +$967K 0.12% 155
2014
Q2 		$6.33M Buy
452,403
+2,087
+0.5% +$31.4K 0.11% 157
2014
Q1 		$7.47M Sell
450,316
-4,573
-1% -$76.6K 0.13% 154
2013
Q4 		$8.56M Buy
454,889
+2,398
+0.5% +$42.1K 0.14% 146
2013
Q3 		$8.52M Sell
452,491
-181,020
-29% -$3.11M 0.16% 140
2013
Q2 		$11.4M Buy
+633,511
New +$10.1M 0.23% 113

Other funds holding NRC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's NRC Position: Q1 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its NRC Health Common Stock (NRC) stake by 0.81% in Q1 2026, selling an estimated $365K and leaving 2,636,355 shares worth $44.8M. The position accounts for 0.13% of the portfolio, ranked #127.

Kayne Anderson Rudnick Investment Management first reported a position in NRC in Q2 2013 and has held it in 52 quarters since. The position peaked at $197M in Q4 2019. 121 funds tracked by Wall St. Rank hold NRC as of Q1 2026.

  • Kayne Anderson Rudnick Investment Management held 2,636,355 shares of NRC Health Common Stock worth $44.8M as of Q1 2026.
  • Kayne Anderson Rudnick Investment Management sold 21,473 NRC Health Common Stock shares in Q1 2026, an estimated $365K.
  • NRC Health Common Stock made up 0.13% of Kayne Anderson Rudnick Investment Management's portfolio in Q1 2026, its #127 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in NRC Health Common Stock in Q2 2013 and has held it in 52 quarters since.
  • Kayne Anderson Rudnick Investment Management's NRC Health Common Stock position peaked at $197M in Q4 2019.
  • 121 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.